Comment on ‘Cutaneous manifestations in COVID‐19: a first perspective’ by Recalcati S
M. Hedou, F. Carsuzaa, Eléonore Chary, E. Hainaut, F. Cazenave‐Roblot, M. Masson Regnault
Abstract
first perspective' by Recalcati S Dear Editor, Since the coronavirus disease 2019 (COVID-19) outbreak was first reported in the Chinese city of Wuhan on 31 December 2019, it has stricken more than 1 000 000 persons worldwide, of whom over 50 000 have died. Isolated sudden onset anosmia has also frequently been reported. Less frequently, rhinorrhea, diarrhoea and dysgeusia may be associated. While only a few reports have evoked cutaneous manifestations, 4 we read with interest an initial study on the topic entitled 'Cutaneous manifestations in COVID-19: a first perspective' by Recalcati S. 5 This Italian study including 88 patients with COVID-19 reported 20.4% of cutaneous manifestations such as erythematous rash, widespread urticaria and chickenpox-like vesicles. In France, while social networking has facilitated communication and exchanges between French doctors, we have not noticed as many skin manifestations.